Ingredion EVP granted 3,053 RSUs

Kalotis Patrick Ilias reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kalotis Patrick Ilias reported acquisition or exercise transactions in this Form 4 filing.

Ingredion Inc EVP Patrick Ilias Kalotis reported receiving an equity award linked to 3,053 shares of common stock. The award consists of restricted stock units granted at a reference value of $117.94 per unit and is held as direct ownership.

The RSUs may be settled only in common stock on a one-for-one basis and are scheduled to vest on February 25, 2029. Vesting can occur on a pro-rata basis upon death, disability, or retirement, and if retirement occurs on or after February 25, 2027, the units continue vesting under the original schedule.

Insights

Equity compensation analyst

Routine time-based RSU grant to an Ingredion executive.

This transaction shows Patrick Ilias Kalotis, an EVP at Ingredion Inc, receiving 3,053 restricted stock units that settle in common shares. The reference value is $117.94 per unit, indicating a notable but typical executive equity award.

The RSUs vest on February 25, 2029, with pro-rata vesting if employment ends due to death, disability, or retirement. If retirement occurs on or after February 25, 2027, vesting continues on schedule. This is standard long-term incentive design and does not, by itself, signal a change in the company’s outlook.

Insider Trade Summary

Grant/Award: 3,053 shares

Grant/Award 1 txn

Insider Kalotis Patrick Ilias

Role EVP, Global Texture & Health

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,053	$117.94	$360K

Holdings After Transaction: Common Stock — 3,053 shares (Direct)

Footnotes (1)

1. F1. These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on February 25, 2029. In the event of termination of employment due to (a) death (b) disability or (c) retirement (as defined in the grant agreement), the RSUs will vest on a pro-rata basis. Notwithstanding the foregoing, in the event of Retirement on or after February 25, 2027, the RSUs shall continue to vest in accordance with the vesting schedule.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ingredion (INGR) report for Patrick Ilias Kalotis?

Ingredion reported that EVP Patrick Ilias Kalotis received a grant of 3,053 restricted stock units. These RSUs are settled only in common stock and represent time-based equity compensation rather than an open-market share purchase or sale transaction.

How many shares are covered by the RSU grant to Ingredion EVP Kalotis?

The RSU grant to EVP Patrick Ilias Kalotis covers 3,053 units, each convertible into one share of Ingredion common stock. This entire amount reflects his directly owned equity award following the transaction as disclosed in the Form 4 filing.

When do the RSUs granted to Ingredion executive Patrick Kalotis vest?

The restricted stock units granted to Patrick Kalotis are scheduled to vest on February 25, 2029. This long-term vesting horizon is designed to align executive incentives with sustained company performance over several years, assuming continued employment and meeting the vesting conditions.

What happens to Ingredion EVP Kalotis’s RSUs if employment ends early?

If Patrick Kalotis’s employment ends due to death, disability, or retirement, his RSUs vest on a pro-rata basis. Additionally, if he retires on or after February 25, 2027, the RSUs continue vesting according to the original vesting schedule, rather than accelerating immediately.

Are the RSUs granted to Ingredion EVP Kalotis settled in cash or stock?

The RSUs granted to Patrick Kalotis may be settled only in Ingredion common stock, one share per unit. This means the award directly links his compensation to the company’s equity value instead of providing a cash-based payout at vesting.

What was the reference value per unit for the RSUs granted at Ingredion?

The Form 4 shows a transaction price of $117.94 per share for Patrick Kalotis’s 3,053 RSUs. This value is typically used as the grant-date fair value reference for the award and helps quantify the size of the equity incentive granted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 12:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalotis Patrick Ilias

(Last) (First) (Middle)

5 WESTBROOK CORPORATE CENTER

(Street)

WESTCHESTER IL 60154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingredion Inc [ INGR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Global Texture & Health

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		3,053(1)	A	$117.94	3,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These are restricted stock units ("RSUs") issued under the Ingredion Incorporated Stock Incentive Plan. The RSUs may be settled only in shares of common stock (one share per RSU) and will vest on February 25, 2029. In the event of termination of employment due to (a) death (b) disability or (c) retirement (as defined in the grant agreement), the RSUs will vest on a pro-rata basis. Notwithstanding the foregoing, in the event of Retirement on or after February 25, 2027, the RSUs shall continue to vest in accordance with the vesting schedule.

	Michael N. Levy, attorney-in-fact	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.